Mr. Cameron Groome reports

MICROBIX HOSTS ONTARIO PREMIER DOUG FORD & TEAM

Microbix Biosystems Inc. has hosted government of Ontario candidates Premier Doug Ford (Etobicoke North riding) and local MPP Deepak Anand (Mississauga-Malton riding). During their site visit on the morning of Feb. 27 -- Ontario's provincial election day -- the company's team had great conversations about how next-generation diagnostic tests can improve health outcomes for patients while also reducing health care costs.

Microbix's chief executive officer, Cameron Groome, commented: "We are very pleased for Microbix to be recognized by candidates Premier Ford and MPP Anand as a leading Ontario-based life sciences company. Our team is developing and manufacturing innovative new products right here in Ontario that are exported and used worldwide to help ensure accurate diagnosis of diseases in a timely manner. It is a privilege to share our insights with senior government leaders in order to benefit Ontario's economy, patients and taxpayers."

Microbix's chief operating officer, Dr. Ken Hughes, also commented: "It is a great pleasure to host Premier Ford and his colleagues at our facilities in Mississauga, and to showcase our innovative, rapidly growing, and profitable manufacturing and export business in the life sciences. The Province of Ontario has been a great supporter of Microbix in recent years, with over $2.0-million of grant funding from its Ontario Together Funds (OTF & OTF2). The success of these OTF initiatives helped lead to the development of many world-leading health care products, while ensuring that Microbix's operations remain firmly rooted here in Ontario."

About Microbix Biosystems Inc.

Microbix Biosystems creates proprietary biological products for human health, with over 120 skilled employees and annualized sales targeting $2-million or more per month. It makes a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical lab accreditation organizations, diagnostics companies and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors. Microbix is ISO 9001 and 13485 accredited, United States Food and Drug Administration registered, Australian Therapeutic Goods Administration registered and Health Canada licensed, and provides IVDR-compliant (in vitro diagnostic regulation), CE-marked products.

Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic urokinase, a biologic thrombolytic drug used to treat blood clots, and viral transport medium (DxTM), to stabilize patient samples for lab-based molecular diagnostic testing. Microbix is headquartered in Mississauga, Ont., Canada.

We seek Safe Harbor.